Craft

Cajal Neuroscience

Total Funding

$96 M

Cajal Neuroscience Summary

Company Summary

Overview
Cajal Neuroscience is a drug discovery company focused on neurodegenerative diseases. It researches genes implicated in neurodegenerative diseases utilizing in vitro and in vivo screening, visualized light-sheet microscopy, sequencing-based axon mapping, scRNA sequencing, etc.
Type
Private
Status
Active
Founded
2020
HQ
Seattle, WA, US | view all locations
Website
https://www.cajalneuro.com/
Cybersecurity rating
Sectors

Key People

  • Ignacio Munoz-Sanjuan

    Ignacio Munoz-Sanjuan, Chief Executive Officer

  • Ian Peikon

    Ian Peikon, Co-founder and Chief Scientific Officer

  • Andrew Dervan

    Andrew Dervan, Co-founder and Chief Operating Officer

  • Julie Harris

    Julie Harris, Vice President, Preclinical Biology

LocationsView all

1 location detected

  • Seattle, WA HQ

    United States

    1616 Eastlake Ave E #300

Footer menu